What is the optimal gastric site to biopsy for eosinophilic gastritis during gastroscopy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Optimal Biopsy Sites for Eosinophilic Gastritis During Gastroscopy

I must clarify that the provided evidence exclusively addresses eosinophilic esophagitis (EoE), not eosinophilic gastritis (EoG), which are distinct conditions requiring different biopsy approaches.

For Eosinophilic Gastritis (Based on Available Research Evidence)

You should obtain at least 8 biopsies from the stomach (including both antrum and corpus) and 4 biopsies from the duodenum to optimize detection of eosinophilic gastritis and duodenitis 1. This systematic approach is critical because:

Key Biopsy Strategy

  • Gastric sampling: Take a minimum of 8 biopsies distributed across multiple gastric sites (antrum and corpus)
  • Duodenal sampling: Obtain at least 4 biopsies from the duodenum
  • Random vs. targeted: Biopsies should be obtained from multiple sites regardless of endoscopic appearance, as eosinophilic infiltration is patchy and unpredictable 1

Critical Rationale

The distribution of eosinophils in eosinophilic gastritis is notably patchy and heterogeneous. In a systematic analysis of 88 patients, only an average of 2.6 out of 8 gastric biopsies and 2.2 out of 4 duodenal biopsies per patient actually met diagnostic thresholds 1. This means that examining fewer biopsies will miss a substantial proportion of cases.

Diagnostic Thresholds

  • Eosinophilic gastritis: ≥30 eosinophils/HPF in at least 5 HPFs (or ≥127 eosinophils/mm²) 2
  • Single-field threshold: 33 eosinophils/HPF (93% sensitivity and specificity) 3
  • Eosinophilic duodenitis: ≥30 eosinophils/HPF in at least 3 HPFs 1
  • Normal gastric eosinophil count: Usually <38 eosinophils/mm² 2

Important Clinical Caveats

Endoscopic appearance does not correlate with eosinophil counts 1. Many patients with eosinophilic gastritis have completely normal-appearing mucosa on endoscopy, making systematic biopsy protocols essential rather than relying on visual abnormalities alone. Neither symptom severity nor endoscopic findings predict the presence or severity of eosinophilic infiltration 1, 4.

Practical Implementation

  1. Antrum: Obtain 4 biopsies from different locations
  2. Corpus/fundus: Obtain 4 biopsies from different locations
  3. Duodenum: Obtain 4 biopsies (both bulb and descending portions)
  4. Avoid: Single-site sampling or relying solely on visually abnormal areas

Additional Considerations

Exclude secondary causes of gastric eosinophilia before diagnosing primary eosinophilic gastritis, including Helicobacter pylori infection (most common secondary cause at 18.8%), Crohn's disease, parasitic infections, drug hypersensitivity, and hypereosinophilic syndrome 5, 4. The term "histologic eosinophilic gastritis" has limitations and may miss clinically significant cases 4.

The evidence strongly supports that inadequate biopsy sampling is a major cause of underdiagnosis in eosinophilic gastritis 6, 1. Taking fewer than 8 gastric and 4 duodenal biopsies significantly reduces diagnostic sensitivity and may result in missed diagnoses with consequent delays in appropriate treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.